Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
104M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
4.48M
-
Shares change
-
+1.41M
-
Total reported value, excl. options
-
$23.9M
-
Value change
-
+$7.57M
-
Number of buys
-
11
-
Number of sells
-
-4
-
Price
-
$5.30
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q3 2016
19 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q3 2016.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.48M shares
of 104M outstanding shares and own 4.32% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (2.93M shares), Southpoint Capital Advisors LP (800K shares), Knoll Capital Management, LP (462K shares), GEODE CAPITAL MANAGEMENT, LLC (101K shares), MORGAN STANLEY (63.9K shares), VANGUARD GROUP INC (38.3K shares), KCG Holdings, Inc. (23.5K shares), GARRISON BRADFORD & ASSOCIATES INC (15.5K shares), NORTHERN TRUST CORP (13.5K shares), and Creative Planning (13.2K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.